Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herman Autrup

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Journal of Toxicology and Environmental Health. Part A|June 20, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Archives of Toxicology|June 10, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Chemico-Biological Interactions|May 7, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Toxicology Letters|May 4, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|May 4, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Regulatory Toxicology and Pharmacology : RTP|July 19, 2018
Obfuscating transparency?Michael Aschner, Herman Autrup, Colin L Berry, et al.
American Journal of Epidemiology|July 16, 2002
Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE reviewLawrence S Engel, Emanuela Taioli, Ruth Pfeiffer, et al.
Cancer Research|July 5, 2006
TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective studyEmmanuelle Gormally, Paolo Vineis, Giuseppe Matullo, et al.
International Journal of Cancer|February 8, 2006
Air pollution and risk of lung cancer in a prospective study in EuropePaolo Vineis, Gerard Hoek, Michal Krzyzanowski, et al.
The British Journal of Nutrition|February 16, 2008
Bulky DNA adducts, 4-aminobiphenyl-haemoglobin adducts and diet in the European Prospective Investigation into Cancer and Nutrition (EPIC) prospective studyMarco Peluso, Luisa Airoldi, Armelle Munnia, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Journal of Toxicology and Environmental Health. Part A|June 20, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Archives of Toxicology|June 10, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Chemico-Biological Interactions|May 7, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Toxicology Letters|May 4, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|May 4, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Regulatory Toxicology and Pharmacology : RTP|July 19, 2018
Obfuscating transparency?Michael Aschner, Herman Autrup, Colin L Berry, et al.
American Journal of Epidemiology|July 16, 2002
Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE reviewLawrence S Engel, Emanuela Taioli, Ruth Pfeiffer, et al.
Cancer Research|July 5, 2006
TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective studyEmmanuelle Gormally, Paolo Vineis, Giuseppe Matullo, et al.
International Journal of Cancer|February 8, 2006
Air pollution and risk of lung cancer in a prospective study in EuropePaolo Vineis, Gerard Hoek, Michal Krzyzanowski, et al.
The British Journal of Nutrition|February 16, 2008
Bulky DNA adducts, 4-aminobiphenyl-haemoglobin adducts and diet in the European Prospective Investigation into Cancer and Nutrition (EPIC) prospective studyMarco Peluso, Luisa Airoldi, Armelle Munnia, et al.
Pageof 10